Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study

被引:19
|
作者
Levy, Liran [1 ]
Tigert, Alexander [1 ]
Huszti, Ella [2 ]
Saito, Tomohito [3 ]
Mitsakakis, Nicholas [2 ]
Moshkelgosha, Sajad [1 ]
Joe, Betty [1 ]
Boonstra, Kristen M. [1 ]
Tikkanen, Jussi M. [1 ]
Keshavjee, Shaf [1 ]
Juvet, Stephen C. [1 ]
Martinu, Tereza [1 ]
机构
[1] Univ Toronto, Univ Hlth Network, Toronto Lung Transplant Program, Toronto, ON, Canada
[2] Univ Toronto, Univ Hlth Network, Biostat Res Unit, Toronto, ON, Canada
[3] Kansai Med Univ, Dept Thorac Surg, Hirakata, Osaka, Japan
基金
加拿大健康研究院;
关键词
bronchoalveolar lavage; epithelial cell death; lung transplant; M30; M65; survival; BRONCHIOLITIS OBLITERANS SYNDROME; IDIOPATHIC PULMONARY-FIBROSIS; CLASSIFICATION; PATHOGENESIS; FORMULATION; TRANSITION; BIOMARKERS; NECROSIS; SERUM; FLUID;
D O I
10.1111/tri.13444
中图分类号
R61 [外科手术学];
学科分类号
摘要
Chronic lung allograft dysfunction (CLAD) remains the leading cause of late death after lung transplantation. Epithelial injury is thought to be a key event in the pathogenesis of CLAD. M30 and M65 are fragments of cytokeratin-18 released specifically during epithelial cell apoptosis and total cell death, respectively. We investigated whether M30 and M65 levels in bronchoalveolar lavage (BAL) correlate with CLAD subtypes: restrictive allograft syndrome (RAS) versus bronchiolitis obliterans syndrome (BOS). BALs were obtained from 26 patients with established CLAD (10 RAS, 16 BOS) and 19 long-term CLAD-free controls. Samples with concurrent infection or acute rejection were excluded. Protein levels were measured by ELISA. Variables were compared using Kruskal-Wallis, Mann-Whitney U test and Chi-squared tests. Association of M30 and M65 levels with post-CLAD survival was assessed using a Cox PH models. M65 levels were significantly higher in RAS compared to BOS and long-term CLAD-free controls and correlated with worse post-CLAD survival. Lung epithelial cell death is enhanced in patients with RAS. Detection of BAL M65 may be used to differentiate CLAD subtypes and as a prognostic marker in patients with established CLAD. Understanding the role of epithelial cell death in CLAD pathogenesis may help identify new therapeutic targets to improve outcome.
引用
收藏
页码:965 / 973
页数:9
相关论文
共 50 条
  • [31] Trends, Determinants, and Impact on Survival of Post-Lung Transplant Weight Changes: A Single-center Longitudinal Retrospective Study
    Jomphe, Valerie
    Nguyen, Cecile
    Durette, Gabrielle
    Chagnon, Miguel
    Nasir, Basil
    Poirier, Charles
    Ferraro, Pasquale
    Lands, Larry C.
    Mailhot, Genevieve
    TRANSPLANTATION, 2019, 103 (12) : 2614 - 2623
  • [32] Long-Term Survival of Lung Transplant Recipients with Connective Tissue Disease and Esophageal Dysfunction: An 11-Year Single-Center Experience
    Sindu, D.
    Latorre-Rodriguez, A. R.
    Patel, S.
    Walia, R.
    Schaheen, L. W.
    Smith, M. A.
    Mittal, S. K.
    Bremner, R. M.
    Tokman, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S475 - S476
  • [33] Formation of donor-specific antibodies depends on the epitope load of mismatched HLAs in lung transplant recipients: A retrospective single-center study
    Lobashevsky, Andrew
    Niemann, Matthias
    Kowinski, Brenda
    Higgins, Nancy
    Abdel-Wareth, Laila
    Atrabulsi, Basel
    Roe, David
    Hage, Chadi
    CLINICAL TRANSPLANTATION, 2022, 36 (09)
  • [34] The Impact of Kinlessness on Survival in Patients With Advanced Non-small Cell Lung Cancer: A Single-Center Retrospective Study
    Omura, Akiisa
    Nojiri, Takashi
    Higashiyama, Masahiko
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [35] FORMATION OF DONOR-SPECIFIC ANTIBODIES DEPENDS ON THE EPITOPE LOAD OF MISMATCHED HLAs IN LUNG TRANSPLANT RECIPIENTS: A RETROSPECTIVE SINGLE-CENTER STUDY.
    Lobashevsky, A.
    Abdel-Wareth, L.
    Altrabulsi, B.
    Higgins, N.
    Niemann, M.
    Kowinski, B.
    Roe, D.
    Hage, C.
    HUMAN IMMUNOLOGY, 2022, 83 : 81 - 82
  • [36] Risks, Management, and Early Outcomes of COVID-19 in Lung Transplant Recipients During the First Year of the Pandemic: A Single-Center Cohort Study
    Cano, M.
    Kulkarni, H.
    Guillamet, R. Vazquez
    Witt, C.
    Alexander-Brett, J.
    Tague, L.
    Halverson, L.
    Nava, R.
    Varun, P.
    Kreisel, D.
    Hachem, R.
    Byers, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [37] Effect of preoperative natural killer cell on postoperative pulmonary complications in patients of lung cancer - A single-center retrospective cohort study
    Yuan, Qinyue
    Wang, Shichao
    Zhu, Haipeng
    Yang, Yulong
    Zhang, Jiaqiang
    Li, Qi
    Huyan, Ting
    Zhang, Wei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 138
  • [38] Survival of M1a Non-Small Cell Lung Cancer Treated Surgically: A Retrospective Single-Center Study
    Liu, Tieqin
    Liu, Hongxu
    Wang, Gebang
    Zhang, Chenlei
    Liu, Bingbing
    THORACIC AND CARDIOVASCULAR SURGEON, 2015, 63 (07): : 577 - 582
  • [39] Survival Risk Analysis of Small Cell Lung Cancer Patients with Pre-Existing Type 2 Diabetes Mellitus: A Single-Center Retrospective Cohort Study
    Ding, Jing
    Li, Xudong
    Ge, Jun
    Gong, Yuanqian
    Zhou, Ya
    Xiao, Juan
    Yang, Qin
    Chen, Jing
    Mao, Mian
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1313 - 1322
  • [40] Outcomes following cryoablation of stage IA non-small cell lung cancer in patients with and without interstitial lung disease: A retrospective single-center cohort study
    Sanger, Jonathan A.
    Graur, Alexander
    Tahir, Ismail
    Price, Melissa C.
    Keane, Florence K.
    Lanuti, Michael
    Sharma, Amita
    Fintelmann, Florian J.
    LUNG CANCER, 2023, 181